🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could lead to individuals administering products of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Platform Response and Content Elimination

According to the social media company, the platform has removed violative material and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.

After minutes of entering one community, a vendor posted WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Product Details and Costs

Within these communities, posts display dark colored parcels with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Although the research behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously encountered individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially serious health risks”.